NCT00078923View on ClinicalTrials.gov

Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

soy isoflavones

PROCEDURE

neoadjuvant therapy

Prostatectomy or Brachytherapy

OTHER

Placebo

Arm I: 4 placebo capsules Arm II: 3 placebo capsules Arm III: 2 placebo capsules

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00078923 - Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate | Biotech Hunter | Biotech Hunter